You are not logged in. | Log in
In Progress
Clinical

Breast cancer

Purpose

This study aimed to facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes.

Hypothesis

Investigation of the biological origins of coordinately expressed genes in breast cancer could clarify the relationship between prognostic gene signatures and tumor pathobiology.

Experimental Design

This dataset consists of breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore). The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Experimental Variables

--

Controls

--

Methods

Breast tumor samples were profiled on the Affymetrix U133A platform.

Additional Information

Nagalla, Srikanth, Jeff W. Chou, Mark C. Willingham, Jimmy Ruiz, James P. Vaughn, Purnima Dubey, Timothy L. Lash, et al. “Interactions between Immunity, Proliferation and Molecular Subtype in Breast Cancer Prognosis.” Genome Biology 14, no. 4 (April 29, 2013): R34. doi:10.1186/gb-2013-14-4-r34.

Microarray
Affymetrix HG-U133A
139 Samples Loaded: 139
Human (Homo sapiens)
National University Hospital, Singapore , Breast Cancer Tissue , John Radcliffe Hospital, Oxford, UK , Institute Jules Bordet, Brussels, Belgium , Nagalla 2013
Mixed Breast Cancer Types
Sample Set Spreadsheet
Please log in in order to upload files.
Samples Preview
Sample ID series IMS IBS IDS ICR
GSM1100037 NA LumA IBD WID ICR4
GSM1100038 NA LumB IBE WID ICR3
GSM1100039 NA Normal IBE NA ICR1
GSM1100040 NA LumA IBD PID ICR1
GSM1100041 NA LumA IBD PID ICR2
Please log in in order to upload files.
File
GSE45255_appended.meta.data_v1.csv
Sample Set Spreadsheet
Log2 Transformed
Raw Signal
  •   |  View in GXB »
Clinical Datasource
Links

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID Series IMS IBS IDS ICR HER2 Status Array Sample ID Sample Title DMFS 10Y EVENT DMFS 10Y TIME Disease Free Survival Event Distant Met Free Survival Event Age At Initial Pathologic Diagnosis Lymph Node Status ER Status PR Status Histology Differentiation Grade Tumor Size Cm Pathology T Stage Disease Free Survival Years Distant Met Free Survival Years Disease Specific Survival Years Treatment Adjuvant Characteristics Endocrine? Chemo? Breast Cancer Cause Of Death Histologic Diagnosis Type Treatment
GSM1100037
NA
LumA
IBD
WID
ICR4
HER2-
400003289
NUH.BT009
DistantMetastasisFree
6.17
DiseaseFree
DistantMetastasisFree
41
LN-
ER+
PR+
G2
2
T1c
6.17
6.17
6.17
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100038
NA
LumB
IBE
WID
ICR3
HER2+
400003290
NUH.BT014
DistantMetastasis
1.13
Recurred/Progressed
DistantMetastasis
62
LN+
ER-
PR-
G2
3
T2
1.13
1.13
1.13
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100039
NA
Normal
IBE
NA
ICR1
HER2-
400003291
NUH.BT018
DistantMetastasisFree
4.29
DiseaseFree
DistantMetastasisFree
69
LN-
ER+
PR+
G2
3
T2
4.29
4.29
4.29
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100040
NA
LumA
IBD
PID
ICR1
HER2-
400003292
NUH.BT019
DistantMetastasisFree
5.88
DiseaseFree
DistantMetastasisFree
69
LN-
ER+
PR+
G2
3.5
T2
5.88
5.88
6.04
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100041
NA
LumA
IBD
PID
ICR2
HER2+
400003293
NUH.BT022
DistantMetastasisFree
2.63
DiseaseFree
DistantMetastasisFree
40
LN-
ER+
PR+
G2
2.5
T2
2.63
2.63
2.63
1
yes
yes
0
invasive ductal carcinoma
Tam+CMFx6 cycles
GSM1100042
NA
Normal
IBE
NA
ICR2
HER2+
400003294
NUH.BT023
DistantMetastasisFree
6.25
DiseaseFree
DistantMetastasisFree
69
LN-
ER+
PR-
G2
2.5
T2
6.25
6.25
6.25
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100043
NA
LumB
IBD
WID
ICR3
HER2+
400003295
NUH.BT029
DistantMetastasis
2
Recurred/Progressed
DistantMetastasis
54
LN+
ER-
PR-
G2
6
T3/T4
2
2
2.25
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100044
NA
Normal
IBE
NA
ICR2
HER2+
400003296
NUH.BT031
DistantMetastasisFree
5.63
DiseaseFree
DistantMetastasisFree
48
LN-
ER+
PR+
G2
2
T1c
5.63
5.63
5.63
NA
NA
NA
0
invasive ductal carcinoma
NA
GSM1100045
NA
Normal
IBE
NA
ICR3
HER2+
400003297
NUH.BT035
DistantMetastasisFree
4.04
DiseaseFree
DistantMetastasisFree
46
LN-
ER-
PR-
G2
1.5
T1c
4.04
4.04
4.08
0
no
no
0
invasive ductal carcinoma
none
GSM1100046
NA
NA
IBE
NA
ICR2
HER2-
400003298
NUH.BT042
DistantMetastasisFree
6
DiseaseFree
DistantMetastasisFree
53
LN-
ER+
PR-
G2
1.8
T1c
6
6
6
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100047
NA
ClaudinLow
IBD
WID
ICR2
HER2-
400003299
NUH.BT046
DistantMetastasisFree
5.79
DiseaseFree
DistantMetastasisFree
52
LN-
ER+
PR+
G2
1.8
T1c
5.79
5.79
5.79
1
no
yes
0
invasive ductal carcinoma
CMF
GSM1100048
NA
LumA
IBD
PID
ICR1
HER2-
400003300
NUH.BT047
DistantMetastasisFree
5.83
DiseaseFree
DistantMetastasisFree
50
LN+
ER-
PR+
G2
2.5
T2
5.83
5.83
5.83
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100049
NA
LumB
IBD
WID
ICR2
HER2-
400003301
NUH.BT049
DistantMetastasisFree
5.75
DiseaseFree
DistantMetastasisFree
53
LN+
ER-
PR+
G2
2.2
T2
5.75
5.75
5.92
1
no
yes
0
invasive ductal carcinoma
CMF
GSM1100050
NA
Normal
IBE
NA
ICR3
HER2+
400003302
NUH.BT054
DistantMetastasisFree
5.58
DiseaseFree
DistantMetastasisFree
77
LN-
ER+
PR-
G2
3.5
T2
5.58
5.58
5.58
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100051
NA
Her2
IBD
PID
ICR2
HER2-
400003303
NUH.BT055
DistantMetastasisFree
6.33
DiseaseFree
DistantMetastasisFree
60
LN-
ER+
PR+
G2
2
T1c
6.33
6.33
6.33
1
yes
yes
0
invasive ductal carcinoma
Tam+CMFx6 cycles
GSM1100052
NA
NA
NA
NA
NA
HER2+
400003304
NUH.BT061
NA
NA
NA
NA
51
LN+
ER+
PR-
G2
2.5
T2
NA
NA
NA
1
yes
yes
NA
invasive ductal carcinoma
Tam+ACx8;taxol
GSM1100053
NA
Basal
IBD
WID
ICR2
HER2-
400003305
NUH.BT067
DistantMetastasisFree
5
DiseaseFree
DistantMetastasisFree
69
LN+
ER+
PR+
G2
2.5
T2
5
5
5
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100054
NA
Her2
IBD
WID
ICR2
HER2+
400003306
NUH.BT068
DistantMetastasisFree
5.25
DiseaseFree
DistantMetastasisFree
49
LN+
ER+
PR+
G2
2.3
T2
5.25
5.25
5.25
1
yes
yes
0
invasive ductal carcinoma
Tam+CAFx6 cycles
GSM1100055
NA
Her2
IBD
PID
ICR1
HER2-
400003307
NUH.BT070
DistantMetastasis
0.04
Recurred/Progressed
DistantMetastasis
48
LN-
ER+
PR-
G2
1.5
T1c
0.04
0.04
3.08
1
no
yes
1
invasive lobular carcinoma
anastrozole;taxol
GSM1100056
NA
LumB
IBD
FID
ICR4
HER2+
400003308
NUH.BT074
DistantMetastasisFree
0.67
Recurred/Progressed
DistantMetastasisFree
75
LN+
ER-
PR+
G2
4
T2
0.92
0.67
5.42
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100057
NA
Her2
IBD
FID
ICR2
HER2+
400003309
NUH.BT078
DistantMetastasis
2.83
Recurred/Progressed
DistantMetastasis
67
LN-
ER-
PR-
G2
2.5
T2
2.83
2.83
2.83
0
no
no
0
invasive ductal carcinoma
none
GSM1100058
NA
Her2
IBE
FID
ICR4
HER2-
400003310
NUH.BT083
DistantMetastasisFree
0.67
Recurred/Progressed
DistantMetastasisFree
55
LN-
ER+
PR+
G2
1.5
T1c
1.25
0.67
4.58
0
no
no
0
invasive ductal carcinoma
none
GSM1100059
NA
Basal
IBE
PID
ICR4
HER2-
400003311
NUH.BT086
DistantMetastasisFree
4.67
DiseaseFree
DistantMetastasisFree
35
LN-
ER-
PR+
G2
4
T2
4.67
4.67
4.67
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100060
NA
Basal
IBE
FID
ICR4
HER2+
400003312
NUH.BT087
DistantMetastasisFree
5.67
DiseaseFree
DistantMetastasisFree
46
LN+
ER+
PR+
G2
3
T2
5.67
5.67
5.67
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100061
NA
Basal
IBE
FID
ICR4
HER2-
400003313
NUH.BT088
DistantMetastasisFree
4.67
DiseaseFree
DistantMetastasisFree
44
LN-
ER+
PR+
G2
3.5
T2
4.67
4.67
4.67
1
no
yes
0
invasive ductal carcinoma
CMF
GSM1100062
NA
ClaudinLow
IBD
PID
ICR1
HER2-
400003314
NUH.BT090
DistantMetastasisFree
5.17
DiseaseFree
DistantMetastasisFree
40
LN+
ER+
PR+
G2
2.3
T2
5.17
5.17
5.17
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100063
NA
LumB
IBD
PID
ICR1
HER2+
400003315
NUH.BT093
DistantMetastasisFree
4.75
DiseaseFree
DistantMetastasisFree
57
LN-
ER+
PR+
G2
2.1
T2
4.75
4.75
4.75
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100064
NA
LumB
IBD
PID
ICR1
HER2-
400003316
NUH.BT094
DistantMetastasisFree
4.92
DiseaseFree
DistantMetastasisFree
55
LN+
ER+
PR+
G2
1.9
T1c
4.92
4.92
4.92
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100065
NA
LumB
IBD
PID
ICR2
HER2+
400003317
NUH.BT095
DistantMetastasisFree
0.42
DiseaseFree
DistantMetastasisFree
44
LN+
ER+
PR+
G2
2.4
T2
0.42
0.42
0.42
0
no
no
0
invasive ductal carcinoma
none
GSM1100066
NA
LumB
IBD
WID
ICR3
HER2+
400003318
NUH.BT096
DistantMetastasis
1.67
Recurred/Progressed
DistantMetastasis
46
LN+
ER+
PR-
G2
6
T3/T4
1.67
1.67
1.75
1
yes
yes
1
invasive ductal carcinoma
Tam+CAFx2 cycles
GSM1100067
NA
LumB
IBD
WID
ICR3
HER2-
400003319
NUH.BT097
DistantMetastasisFree
4.5
DiseaseFree
DistantMetastasisFree
42
LN+
ER+
PR-
G2
3
T2
4.5
4.5
4.5
NA
NA
NA
0
invasive ductal carcinoma
NA
GSM1100068
NA
LumA
IBD
PID
ICR1
HER2-
400003320
NUH.BT103
DistantMetastasisFree
4.88
DiseaseFree
DistantMetastasisFree
46
LN-
ER+
PR+
G2
1.5
T1c
4.88
4.88
4.88
1
yes
yes
0
invasive ductal carcinoma
Tam+CMFx6 cycles
GSM1100069
NA
Her2
IBD
PID
ICR1
HER2-
400003321
NUH.BT104
DistantMetastasisFree
4.83
DiseaseFree
DistantMetastasisFree
73
LN+
ER+
PR+
G2
2
T1c
4.83
4.83
4.92
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100070
NA
LumB
IBD
PID
ICR1
HER2-
400003322
NUH.BT108
DistantMetastasisFree
4
DiseaseFree
DistantMetastasisFree
46
LN+
ER-
PR+
G2
4
T2
4
4
4.5
NA
NA
NA
0
invasive ductal and lobular carcinoma
NA
GSM1100071
NA
NA
NA
NA
NA
HER2+
400003323
NUH.BT111
NA
NA
NA
NA
66
LN-
ER+
PR+
G2
1.7
T1c
NA
NA
0.08
NA
NA
NA
0
invasive ductal carcinoma
NA
GSM1100072
NA
LumB
IBD
WID
ICR1
HER2-
400003324
NUH.BT113
DistantMetastasisFree
5.58
DiseaseFree
DistantMetastasisFree
64
LN-
ER+
PR+
G2
1.2
T1c
5.58
5.58
5.58
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100073
NA
LumA
IBD
WID
ICR3
HER2-
400003325
NUH.BT114
DistantMetastasisFree
5.33
DiseaseFree
DistantMetastasisFree
49
LN-
ER+
PR+
G2
1.5
T1c
5.33
5.33
5.33
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100074
NA
ClaudinLow
IBD
PID
ICR1
HER2-
400003326
NUH.BT119
DistantMetastasisFree
5
DiseaseFree
DistantMetastasisFree
47
LN-
ER+
PR+
G2
3.5
T2
5
5
5
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100075
NA
Basal
IBD
PID
ICR1
HER2+
400003327
NUH.BT001
DistantMetastasisFree
1.54
DiseaseFree
DistantMetastasisFree
34
LN-
ER-
PR-
G3
4
T2
1.54
1.54
5.46
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100076
NA
Normal
IBE
NA
ICR2
HER2-
400003328
NUH.BT010
DistantMetastasisFree
5.46
DiseaseFree
DistantMetastasisFree
45
LN-
ER+
PR+
G1
1.5
T1c
5.46
5.46
5.46
1
yes
no
0
invasive ductal carcinoma
tamoxifen;goserelin
GSM1100077
NA
LumA
IBD
WID
ICR4
HER2+
400003329
NUH.BT100
DistantMetastasisFree
4.46
DiseaseFree
DistantMetastasisFree
55
LN-
ER+
PR+
G3
2
T1c
4.46
4.46
4.46
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100078
NA
LumA
IBD
WID
ICR3
HER2-
400003330
NUH.BT101
DistantMetastasisFree
4.88
DiseaseFree
DistantMetastasisFree
47
LN+
ER+
PR+
G3
3.2
T2
4.88
4.88
4.88
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100079
NA
Basal
IBD
PID
ICR1
HER2-
400003331
NUH.BT102
DistantMetastasisFree
0.13
DiseaseFree
DistantMetastasisFree
66
LN-
ER+
PR+
G1
3.8
T2
NA
0.13
0.13
1
yes
no
0
mucinous carcinoma
tamoxifen
GSM1100080
NA
LumA
IBD
PID
ICR2
HER2+
400003332
NUH.BT107
DistantMetastasisFree
1
DiseaseFree
DistantMetastasisFree
55
LN-
ER-
PR-
G3
6
T3/T4
1
1
5
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100081
NA
LumA
IBD
WID
ICR3
HER2+
400003333
NUH.BT110
DistantMetastasisFree
4
DiseaseFree
DistantMetastasisFree
52
LN+
ER-
PR-
G3
3.5
T2
4
4
4.33
1
no
yes
0
invasive lobular carcinoma
ACx4 cycles
GSM1100082
NA
Basal
IBE
PID
ICR2
HER2+
400003334
NUH.BT112
DistantMetastasis
2.04
Recurred/Progressed
DistantMetastasis
74
LN+
ER+
PR-
G3
3
T2
2.04
2.04
2.25
1
yes
no
1
invasive ductal carcinoma
tamoxifen
GSM1100083
NA
Basal
IBE
PID
ICR2
NA
400003335
NUH.BT117
DistantMetastasisFree
4
DiseaseFree
DistantMetastasisFree
44
LN+
ER-
PR-
G3
5
T2
4
4
4
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100084
NA
Her2
IBE
FID
ICR3
HER2+
400003336
NUH.BT012
DistantMetastasis
3.96
Recurred/Progressed
DistantMetastasis
54
LN+
ER-
PR-
G3
2
T1c
3.96
3.96
4.63
1
no
yes
1
invasive ductal carcinoma
ACx4 cycles
GSM1100085
NA
LumA
IBD
WID
ICR2
HER2+
400003337
NUH.BT120
DistantMetastasisFree
5.25
DiseaseFree
DistantMetastasisFree
45
LN+
ER+
PR+
G3
2.5
T2
5.25
5.25
5.29
1
no
yes
0
invasive ductal carcinoma
AC
GSM1100086
NA
LumA
IBD
WID
ICR3
HER2+
400003338
NUH.BT013
DistantMetastasisFree
1.96
DiseaseFree
DistantMetastasisFree
58
LN+
ER+
PR+
G3
3
T2
1.96
1.96
1.96
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100087
NA
ClaudinLow
IBD
WID
ICR3
HER2+
400003339
NUH.BT015
DistantMetastasis
0.001
Recurred/Progressed
DistantMetastasis
62
LN+
ER+
PR+
G3
2.5
T2
0
0
2.08
1
yes
yes
1
invasive ductal carcinoma
Arimidex+CMFx2 cycles
GSM1100088
NA
Her2
IBD
PID
ICR1
HER2+
400003340
NUH.BT016
DistantMetastasis
0.88
Recurred/Progressed
DistantMetastasis
62
LN+
ER-
PR-
G3
3.5
T2
0.88
0.88
1
0
no
no
0
invasive ductal carcinoma
none
GSM1100089
NA
Normal
IBE
NA
ICR3
HER2+
400003341
NUH.BT017
DistantMetastasisFree
5.08
DiseaseFree
DistantMetastasisFree
64
LN-
ER-
PR-
G3
3
T2
5.08
5.08
5.08
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100090
NA
Normal
IBE
NA
ICR4
HER2+
400003342
NUH.BT002
DistantMetastasisFree
4.83
DiseaseFree
DistantMetastasisFree
45
LN+
ER-
PR-
G3
2
T1c
4.83
4.83
4.83
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100091
NA
LumA
IBD
WID
ICR2
HER2-
400003343
NUH.BT020
DistantMetastasis
1.96
Recurred/Progressed
DistantMetastasis
80
LN+
ER+
PR+
G3
4
T2
1.96
1.96
1.96
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100092
NA
LumA
IBD
FID
ICR4
HER2-
400003344
NUH.BT003
DistantMetastasisFree
5.54
DiseaseFree
DistantMetastasisFree
41
LN-
ER-
PR-
G3
4
T2
5.54
5.54
5.54
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100093
NA
LumB
IBE
PID
ICR1
HER2+
400003345
NUH.BT033
DistantMetastasis
0.13
Recurred/Progressed
DistantMetastasis
46
LN+
ER-
PR-
G3
2.2
T2
0.13
0.13
0.38
NA
NA
NA
1
invasive ductal carcinoma
NA
GSM1100094
NA
LumA
IBD
FID
ICR3
HER2+
400003346
NUH.BT034
DistantMetastasis
1.29
Recurred/Progressed
DistantMetastasis
54
LN+
ER-
PR-
G3
3.5
T2
1.29
1.29
1.38
1
no
yes
1
invasive ductal carcinoma
CAF
GSM1100095
NA
LumB
IBD
PID
ICR1
HER2-
400003347
NUH.BT036
DistantMetastasisFree
3.13
DiseaseFree
DistantMetastasisFree
86
LN+
ER+
PR+
G1
2.1
T2
3.13
3.13
4.38
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100096
NA
ClaudinLow
IBD
FID
ICR4
HER2-
400003348
NUH.BT037
DistantMetastasis
2.21
Recurred/Progressed
DistantMetastasis
29
LN+
ER+
PR+
G1
8
T3/T4
2.21
2.21
3.04
1
no
yes
1
invasive lobular carcinoma
CAFx6 cycles
GSM1100097
NA
LumB
IBD
PID
ICR3
HER2+
400003349
NUH.BT038
DistantMetastasisFree
4.38
DiseaseFree
DistantMetastasisFree
34
LN+
ER+
PR+
G3
3.5
T2
4.38
4.38
4.38
1
no
yes
0
invasive ductal carcinoma
ACx8 cycles; taxol
GSM1100098
NA
LumB
IBE
PID
ICR3
HER2-
400003350
NUH.BT039
DistantMetastasisFree
5.08
DiseaseFree
DistantMetastasisFree
48
LN+
ER-
PR-
G3
3
T2
5.08
5.08
5.08
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100099
NA
LumA
IBD
WID
ICR3
HER2-
400003351
NUH.BT004
DistantMetastasisFree
4.17
DiseaseFree
DistantMetastasisFree
42
LN-
ER-
PR-
G3
2.2
T2
4.17
4.17
4.25
1
no
yes
0
invasive ductal carcinoma
AC
GSM1100100
NA
Her2
IBD
WID
ICR2
HER2-
400003352
NUH.BT040
DistantMetastasisFree
0.75
DiseaseFree
DistantMetastasisFree
48
LN-
ER-
PR-
G3
3.5
T2
0.75
0.75
0.75
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100101
NA
LumB
IBD
PID
ICR1
HER2+
400003353
NUH.BT041
DistantMetastasisFree
6.29
DiseaseFree
DistantMetastasisFree
52
LN+
ER+
PR+
G3
4.5
T2
6.29
6.29
6.29
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100102
NA
Normal
IBE
NA
ICR1
HER2-
400003354
NUH.BT043
DistantMetastasisFree
5.58
DiseaseFree
DistantMetastasisFree
60
LN-
ER+
PR+
G1
1.5
T1c
5.58
5.58
5.79
1
yes
yes
0
invasive ductal carcinoma
Tam+CMFx6 cycles
GSM1100103
NA
LumB
IBE
PID
ICR1
HER2+
400003355
NUH.BT045
DistantMetastasis
0.79
Recurred/Progressed
DistantMetastasis
51
LN+
ER-
PR-
G3
3
T2
0.79
0.79
1.46
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100104
NA
LumA
IBD
WID
ICR2
HER2+
400003356
NUH.BT048
DistantMetastasis
2.29
Recurred/Progressed
DistantMetastasis
38
LN-
ER+
PR-
G3
3.6
T2
2.29
2.29
2.88
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100105
NA
LumA
IBD
FID
ICR4
HER2+
400003357
NUH.BT005
DistantMetastasisFree
4
DiseaseFree
DistantMetastasisFree
42
LN-
ER-
PR-
G3
2.3
T2
4
4
4
NA
NA
NA
0
invasive ductal carcinoma
NA
GSM1100106
NA
NA
NA
NA
NA
HER2-
400003358
NUH.BT050
NA
NA
NA
NA
81
LN-
ER+
PR+
G1
4
T2
NA
NA
NA
1
yes
no
NA
papillary carcinoma
tamoxifen
GSM1100107
NA
LumA
IBD
WID
ICR2
HER2-
400003359
NUH.BT051
DistantMetastasisFree
3.5
DiseaseFree
DistantMetastasisFree
77
LN-
ER+
PR+
G1
4
T2
3.5
3.5
4.33
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100108
NA
Normal
IBE
NA
ICR3
HER2-
400003360
NUH.BT052
DistantMetastasisFree
1.17
DiseaseFree
DistantMetastasisFree
42
LN-
ER-
PR-
G3
2
T1c
1.17
1.17
6.5
0
no
no
0
medullary carcinoma
none
GSM1100109
NA
LumA
IBD
PID
ICR1
HER2-
400003361
NUH.BT053
DistantMetastasisFree
5.88
DiseaseFree
DistantMetastasisFree
61
LN+
ER+
PR-
G3
2.5
T2
5.88
5.88
5.88
1
no
yes
0
invasive ductal carcinoma
CMF
GSM1100110
NA
LumA
IBD
PID
ICR1
HER2+
400003362
NUH.BT056
DistantMetastasisFree
5.71
DiseaseFree
DistantMetastasisFree
48
LN-
ER-
PR-
G3
3.2
T2
5.71
5.71
5.71
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100111
NA
Basal
IBD
FID
ICR3
HER2+
400003363
NUH.BT059
DistantMetastasisFree
5.83
DiseaseFree
DistantMetastasisFree
61
LN+
ER-
PR-
G3
1.5
T1c
5.83
5.83
5.83
1
no
yes
0
invasive ductal carcinoma
CAFx6 cycles
GSM1100112
NA
LumA
IBD
FID
ICR3
HER2-
400003364
NUH.BT006
DistantMetastasisFree
6.17
DiseaseFree
DistantMetastasisFree
36
LN-
ER+
PR+
G3
2.5
T2
6.17
6.17
6.17
1
yes
yes
0
invasive ductal carcinoma
Tam+CMFx6 cycles
GSM1100113
NA
Basal
IBE
PID
ICR1
HER2+
400003365
NUH.BT060
DistantMetastasisFree
1.33
Recurred/Progressed
DistantMetastasisFree
51
LN-
ER-
PR-
G3
2.7
T2
1.92
1.33
5.58
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100114
NA
LumB
IBE
WID
ICR3
HER2-
400003366
NUH.BT062
DistantMetastasisFree
5.83
DiseaseFree
DistantMetastasisFree
46
LN-
ER-
PR-
G3
2.5
T2
5.83
5.83
5.83
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100115
NA
Her2
IBE
WID
ICR4
HER2+
400003367
NUH.BT063
DistantMetastasisFree
5.83
DiseaseFree
DistantMetastasisFree
48
LN-
ER-
PR-
G3
3.5
T2
5.83
5.83
5.83
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100116
NA
Basal
IBE
PID
ICR2
HER2-
400003368
NUH.BT064
DistantMetastasisFree
5.79
DiseaseFree
DistantMetastasisFree
51
LN-
ER+
PR-
G3
1.8
T1c
5.79
5.79
5.79
1
yes
yes
0
invasive ductal carcinoma
Tam+CMFx6 cycles
GSM1100117
NA
Her2
IBD
PID
ICR2
HER2+
400003369
NUH.BT065
DistantMetastasisFree
5.88
DiseaseFree
DistantMetastasisFree
47
LN-
ER-
PR-
G3
2.1
T2
5.88
5.88
5.88
1
no
yes
0
invasive ductal carcinoma
ACx4 cycles
GSM1100118
NA
LumA
IBD
PID
ICR2
HER2+
400003370
NUH.BT066
DistantMetastasisFree
5.92
DiseaseFree
DistantMetastasisFree
58
LN+
ER+
PR+
G3
5.1
T3/T4
5.92
5.92
5.92
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100119
NA
LumA
IBD
WID
ICR3
HER2+
400003371
NUH.BT007
DistantMetastasisFree
5.58
DiseaseFree
DistantMetastasisFree
38
LN-
ER+
PR+
G3
3.8
T2
5.58
5.58
5.58
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100120
NA
Basal
IBE
PID
ICR1
HER2-
400003372
NUH.BT071
DistantMetastasisFree
4.54
DiseaseFree
DistantMetastasisFree
47
LN+
ER+
PR+
G3
3
T2
4.54
4.54
4.54
1
no
yes
0
invasive ductal carcinoma
CAF
GSM1100121
NA
Basal
IBE
FID
ICR4
HER2+
400003373
NUH.BT072
DistantMetastasisFree
5.21
DiseaseFree
DistantMetastasisFree
64
LN-
ER+
PR+
G3
5
T2
5.21
5.21
5.21
1
yes
no
0
medullary carcinoma
tamoxifen
GSM1100122
NA
Her2
IBE
WID
ICR2
HER2+
400003374
NUH.BT073
DistantMetastasis
3.83
Recurred/Progressed
DistantMetastasis
50
LN+
ER-
PR+
G3
1.6
T1c
3.83
3.83
5.75
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100123
NA
Her2
IBD
FID
ICR3
HER2-
400003375
NUH.BT076
DistantMetastasisFree
5.17
DiseaseFree
DistantMetastasisFree
52
LN-
ER+
PR+
G1
2
T1c
5.17
5.17
5.17
1
yes
no
0
invasive lobular carcinoma
tamoxifen
GSM1100124
NA
LumB
IBE
WID
ICR3
HER2+
400003376
NUH.BT077
DistantMetastasisFree
4.92
DiseaseFree
DistantMetastasisFree
67
LN+
ER+
PR-
G3
2.5
T2
4.92
4.92
4.92
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100125
NA
Normal
IBE
NA
ICR3
HER2+
400003377
NUH.BT008
DistantMetastasis
2
Recurred/Progressed
DistantMetastasis
38
LN+
ER+
PR+
G3
4
T2
2
2
2
1
yes
yes
0
invasive ductal carcinoma
Tam+AC
GSM1100126
NA
LumB
IBE
PID
ICR3
HER2-
400003378
NUH.BT082
DistantMetastasisFree
0.83
DiseaseFree
DistantMetastasisFree
84
LN-
ER+
PR+
G3
2.8
T2
0.83
0.83
0.83
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100127
NA
Normal
IBE
NA
ICR2
NA
400003379
NUH.BT084
DistantMetastasisFree
4.67
DiseaseFree
DistantMetastasisFree
55
LN-
NA
NA
G1
2.5
T2
4.67
4.67
4.67
0
no
no
0
invasive ductal carcinoma and papillary carcinoma
none
GSM1100128
NA
ClaudinLow
IBD
WID
ICR2
HER2-
400003380
NUH.BT089
DistantMetastasisFree
2.67
DiseaseFree
DistantMetastasisFree
43
LN+
ER+
PR+
G1
2.4
T2
2.67
2.67
2.67
1
yes
yes
0
invasive ductal carcinoma
Tam+ACx4 cycles
GSM1100129
NA
LumB
IBD
WID
ICR2
HER2-
400003381
NUH.BT091
DistantMetastasisFree
4.38
DiseaseFree
DistantMetastasisFree
62
LN-
ER+
PR+
G3
2
T1c
4.38
4.38
4.38
1
yes
no
0
invasive ductal carcinoma
tamoxifen
GSM1100130
NA
Her2
IBD
PID
ICR1
HER2-
400003382
NUH.BT092
DistantMetastasisFree
4.83
DiseaseFree
DistantMetastasisFree
59
LN+
ER+
PR+
G1
6
T3/T4
4.83
4.83
4.83
NA
NA
NA
0
invasive ductal carcinoma
NA
GSM1100131
NA
LumB
IBD
PID
ICR1
NA
400003383
NUH.BT099
DistantMetastasisFree
4.33
DiseaseFree
DistantMetastasisFree
53
LN+
ER+
PR+
G3
3.5
T2
4.33
4.33
4.33
1
yes
yes
0
invasive ductal carcinoma
Tam+CMFx6 cycles
GSM1100132
NA
Her2
IBD
PID
ICR1
HER2+
400003384
95_1279
DistantMetastasis
3.05
NA
DistantMetastasis
63
LN-
ER+
NA
G2
3
T2
NA
3.05
3.449315068
1
yes
no
1
NA
Tamoxifen
GSM1100133
NA
Her2
IBE
PID
ICR3
HER2+
400003385
95_9670
DistantMetastasis
1.39
NA
DistantMetastasis
47
LN-
ER+
PR+
G3
2.8
T2
NA
1.39
2.126027397
1
yes
yes
1
NA
CMFx6; Tamoxifen
GSM1100134
NA
Her2
IBE
FID
ICR3
HER2+
400003386
96_6784
DistantMetastasis
0.65
NA
DistantMetastasis
59
LN-
ER-
PR-
G3
2.5
T2
NA
0.65
3.079452055
1
yes
no
1
NA
Tamoxifen
GSM1100135
NA
LumB
IBE
PID
ICR2
HER2-
400003387
96_8645
DistantMetastasis
4.18
NA
DistantMetastasis
66
LN-
ER-
PR-
G3
2.1
T2
NA
4.18
4.194520548
1
yes
no
1
NA
Tamoxifen
GSM1100136
NA
LumB
IBD
PID
ICR1
HER2-
400003388
97_4970
DistantMetastasis
4.51
NA
DistantMetastasis
68
LN-
ER+
PR+
G3
1.7
T1c
NA
4.51
6.17260274
1
yes
no
1
NA
Tamoxifen
GSM1100137
NA
Her2
IBD
FID
ICR4
HER2+
400003389
97_2461
DistantMetastasis
0.25
NA
DistantMetastasis
57
LN-
ER+
PR+
NA
8.5
T3/T4
NA
0.25
5.035616438
1
yes
no
1
NA
Tamoxifen
GSM1100138
NA
LumB
IBE
PID
ICR1
HER2-
400003390
97_6230
DistantMetastasis
1.35
NA
DistantMetastasis
38
LN-
ER+
PR-
G3
3.2
T2
NA
1.35
2.753424658
1
yes
yes
1
NA
ECx4; Tamoxifen
GSM1100139
NA
LumB
IBE
PID
ICR1
HER2-
400003391
97_10495
DistantMetastasis
2.21
NA
DistantMetastasis
63
LN-
ER+
PR+
G3
4.6
T2
NA
2.21
4.928767123
1
yes
no
1
NA
Tamoxifen
GSM1100140
NA
Basal
IBE
PID
ICR2
HER2-
400003392
98_1467
DistantMetastasis
3.8
NA
DistantMetastasis
73
LN-
ER-
PR-
G3
3.4
T2
NA
3.8
4.621917808
1
no
yes
1
NA
ACx3/CMFx1
GSM1100141
NA
LumB
IBE
PID
ICR1
HER2+
400003393
00_4773
DistantMetastasis
0.76
NA
DistantMetastasis
70
LN-
ER+
PR+
G3
3.5
T2
NA
0.76
0.991780822
1
yes
no
1
NA
Tamoxifen
GSM1100142
NA
LumA
IBD
WID
ICR3
HER2-
400003394
97_3659
DistantMetastasisFree
2.18
NA
DistantMetastasisFree
46
LN-
ER+
PR-
G1
1
T1b
NA
2.18
2.189041096
1
yes
yes
0
NA
Tamoxifen+Zoledronic acid
GSM1100143
NA
LumB
IBD
PID
ICR2
HER2-
400003395
95_5655
DistantMetastasis
2.42
NA
DistantMetastasis
36
LN-
ER-
PR-
G2
1.3
T1c
NA
2.42
7.079452055
1
yes
yes
0
NA
Tamoxifen+Zoledronic acid
GSM1100144
NA
LumA
IBD
WID
ICR2
HER2-
400003396
96_1378
DistantMetastasis
6.15
NA
DistantMetastasis
54
LN-
ER+
PR-
G1
5.5
T3/T4
NA
6.15
8.021917808
1
no
yes
0
NA
ACx4
GSM1100145
NA
LumB
IBD
WID
ICR3
HER2-
400003397
97_2927
DistantMetastasis
3.65
NA
DistantMetastasis
60
LN-
ER+
PR+
G3
4
T2
NA
3.65
6.750684932
1
yes
yes
0
NA
CMFx2; Tamoxifen
GSM1100146
NA
LumB
IBD
WID
ICR2
HER2+
400003398
98_478
DistantMetastasis
3.3
NA
DistantMetastasis
72
LN-
ER+
PR+
G3
3.7
T2
NA
3.3
5.164383562
1
yes
no
0
NA
Arimidex/Tamoxifen
GSM1100147
NA
LumB
IBE
FID
ICR4
HER2-
400003399
95_5029
DistantMetastasisFree
7.82
NA
DistantMetastasisFree
54
LN-
ER-
PR-
G2
1
T1b
NA
7.82
7.821917808
1
yes
no
0
NA
Tamoxifen
GSM1100148
NA
Her2
IBE
PID
ICR3
HER2+
400003400
94_14421
DistantMetastasisFree
7.85
NA
DistantMetastasisFree
48
LN-
ER+
NA
G2
1.2
T1c
NA
7.85
7.854794521
1
yes
yes
0
NA
Tamoxifen+Zoledronic acid
GSM1100149
NA
LumB
IBD
WID
ICR3
HER2-
400003401
95_6413
DistantMetastasisFree
7.31
NA
DistantMetastasisFree
55
LN-
ER+
PR+
G3
1.8
T1c
NA
7.31
7.306849315
1
yes
no
0
NA
Tamoxifen
GSM1100150
NA
Her2
IBD
PID
ICR1
HER2+
400003402
95_11893
DistantMetastasisFree
7.57
NA
DistantMetastasisFree
81
LN-
ER+
PR-
G2
2
T1c
NA
7.57
7.57260274
1
yes
no
0
NA
Tamoxifen
GSM1100151
NA
Normal
IBE
NA
ICR2
HER2+
400003403
96_4793
DistantMetastasisFree
6.02
NA
DistantMetastasisFree
52
LN-
ER-
PR-
G2
2
T1c
NA
6.02
6.019178082
1
yes
yes
0
NA
ACx4; Tamoxifen
GSM1100152
NA
LumA
IBD
PID
ICR1
HER2+
400003404
97_938
DistantMetastasisFree
6.18
NA
DistantMetastasisFree
77
LN-
ER+
PR+
G2
1.5
T1c
NA
6.18
6.175342466
1
yes
no
0
NA
Tamoxifen
GSM1100153
NA
LumB
IBD
WID
ICR3
HER2+
400003405
96_3800
DistantMetastasisFree
6.65
NA
DistantMetastasisFree
70
LN-
ER+
PR-
G2
3.5
T2
NA
6.65
6.652054795
1
yes
no
0
NA
Tamoxifen
GSM1100154
NA
Basal
IBE
WID
ICR3
HER2-
400003406
96_2614
DistantMetastasisFree
6.61
NA
DistantMetastasisFree
67
LN-
ER-
PR-
G3
4
T2
NA
6.61
6.61369863
1
yes
yes
0
NA
ACx6; Tamoxifen
GSM1100155
NA
Her2
IBE
WID
ICR3
HER2+
400003407
96_3132
DistantMetastasisFree
6.13
NA
DistantMetastasisFree
62
LN-
ER+
PR+
G3
2.7
T2
NA
6.13
6.128767123
1
yes
no
0
NA
Tamoxifen
GSM1100156
NA
LumA
IBD
PID
ICR1
HER2-
400003408
96_8234
DistantMetastasisFree
5.94
NA
DistantMetastasisFree
66
LN-
ER+
PR+
G1
2.7
T2
NA
5.94
5.936986301
1
yes
no
0
NA
Tamoxifen
GSM1100157
NA
LumA
IBD
PID
ICR1
HER2+
400003409
96_14641
DistantMetastasisFree
3.12
NA
DistantMetastasisFree
57
LN-
ER+
PR-
G1
2
T1c
NA
3.12
3.115068493
1
yes
no
0
NA
Tamoxifen
GSM1100158
NA
LumB
IBE
WID
ICR3
NA
400003410
96_9210
DistantMetastasisFree
2.57
NA
DistantMetastasisFree
46
LN-
NA
NA
G3
3.2
T2
NA
2.57
2.57260274
1
yes
yes
0
NA
CMFx6; Tamoxifen
GSM1100159
NA
ClaudinLow
IBD
PID
ICR1
HER2-
400003411
96_12695
DistantMetastasisFree
6.19
NA
DistantMetastasisFree
73
LN-
ER-
PR-
NA
3.8
T2
NA
6.19
6.18630137
NA
NA
NA
0
NA
NA
GSM1100160
NA
LumA
IBD
WID
ICR2
HER2-
400003412
97_1564
DistantMetastasisFree
6.69
NA
DistantMetastasisFree
42
LN-
ER+
PR+
G2
1.4
T1c
NA
6.69
6.693150685
1
no
yes
0
NA
CMFx6
GSM1100161
NA
LumB
IBE
FID
ICR4
HER2-
400003413
97_3340
DistantMetastasisFree
5.52
NA
DistantMetastasisFree
53
LN-
ER+
PR+
G3
1.9
T1c
NA
5.52
5.523287671
1
yes
no
0
NA
Tamoxifen
GSM1100162
NA
LumA
IBD
PID
ICR1
HER2-
400003414
97_5410
DistantMetastasisFree
5.11
NA
DistantMetastasisFree
60
LN-
ER+
PR+
G3
2
T1c
NA
5.11
5.109589041
1
yes
yes
0
NA
ACx4; Arimidex/Tamoxifen
GSM1100163
NA
Basal
IBE
WID
ICR3
HER2-
400003415
97_7954
DistantMetastasisFree
5.57
NA
DistantMetastasisFree
61
LN-
ER-
PR-
G3
1.4
T1c
NA
5.57
5.567123288
1
yes
yes
0
NA
CMFx6; Arimidex/Tamoxifen
GSM1100164
NA
Her2
IBE
FID
ICR3
NA
400003416
97_10321
DistantMetastasisFree
6.26
NA
DistantMetastasisFree
59
LN-
ER-
PR-
G3
4.5
T2
NA
6.26
6.257534247
1
no
yes
0
NA
ACx4
GSM1100165
NA
LumB
IBD
PID
ICR1
HER2-
400003417
97_10569
DistantMetastasisFree
5.13
NA
DistantMetastasisFree
70
LN-
ER+
PR-
G2
2
T1c
NA
5.13
5.134246575
1
yes
no
0
NA
Tamoxifen
GSM1100166
NA
LumA
IBD
PID
ICR2
HER2-
400003418
97_9201
DistantMetastasisFree
4.64
NA
DistantMetastasisFree
45
LN-
ER+
PR+
G2
2
T1c
NA
4.64
4.643835616
1
no
yes
0
NA
CMFx6
GSM1100167
NA
Basal
IBE
PID
ICR2
HER2+
400003419
98_176
DistantMetastasisFree
5.01
NA
DistantMetastasisFree
48
LN-
ER-
PR-
G3
6
T3/T4
NA
5.01
5.008219178
1
no
yes
0
NA
CMFx6
GSM1100168
NA
LumA
IBD
PID
ICR2
HER2+
400003420
97_12101
DistantMetastasisFree
4.56
NA
DistantMetastasisFree
45
LN-
ER+
PR+
G2
3
T2
NA
4.56
4.561643836
1
yes
no
0
NA
Tamoxifen
GSM1100169
NA
Basal
IBE
FID
ICR4
HER2-
400003421
98_301
DistantMetastasisFree
4.96
NA
DistantMetastasisFree
46
LN-
ER-
PR-
G3
2.7
T2
NA
4.96
4.95890411
1
yes
yes
0
NA
CMFx6; Tamoxifen
GSM1100170
NA
LumA
IBD
WID
ICR2
HER2+
400003422
98_8377
DistantMetastasisFree
3.93
NA
DistantMetastasisFree
56
LN-
ER+
PR+
G1
3
T2
NA
3.93
3.926027397
1
yes
no
0
NA
Tamoxifen
GSM1100171
NA
LumB
IBD
FID
ICR4
HER2-
400003423
98_2095
DistantMetastasisFree
4.51
NA
DistantMetastasisFree
72
LN-
ER+
PR-
G2
2
T1c
NA
4.51
4.509589041
1
yes
no
0
NA
Tamoxifen
GSM1100172
NA
ClaudinLow
IBD
FID
ICR3
HER2-
400003424
01_1620
DistantMetastasisFree
1.66
NA
DistantMetastasisFree
50
LN-
ER-
PR-
G3
2.9
T2
NA
1.66
1.660273973
1
no
yes
0
NA
CMFx6
GSM1100173
NA
ClaudinLow
IBD
FID
ICR3
NA
400003425
OXFU_369
DistantMetastasis
7.15
Recurred/Progressed
DistantMetastasis
67
LN-
ER-
NA
NA
1
T1b
7.15
7.151
NA
0
no
no
NA
NA
none
GSM1100174
NA
ClaudinLow
IBD
FID
ICR3
NA
400003426
OXFU_410
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
37
LN-
ER-
NA
G2
2.3
T2
10.61
10.614
NA
0
no
no
NA
NA
none
GSM1100175
NA
ClaudinLow
IBD
FID
ICR3
NA
400003427
OXFU_554
DistantMetastasisFree
9.42
DiseaseFree
DistantMetastasisFree
43
LN-
ER+
NA
G1
2.1
T2
9.42
9.419
NA
0
no
no
NA
NA
none

Group Sets View in Gene Expression Browser

Name  
All Samples Default  View
ER Status   View
Histology Differentiation Grade   View
Immune Benefit Status   View
Immunological Constant of Rejection   View
Lymph Node Status   View
Molecular Subtype   View
Pathology T Stage   View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set  
All Samples
ER Status
Histology Differentiation Grade
Immune Benefit Status
Immunological Constant of Rejection
Lymph Node Status
Molecular Subtype
Pathology T Stage
Your bug report has been sent!